Reinforcement of cancer immunotherapy by adoptive transfer of cblb -deficient CD8+ T cells combined with a DC vaccine

Abrogating Cbl-b in effector CD8+ T cells improves the efficacy of adoptive therapy of leukemia in mice

(2010) Ingunn M. Stromnes et al.   JOURNAL OF CLINICAL INVESTIGATION

Cbl-b-/- T Cells Demonstrate In Vivo Resistance to Regulatory T Cells but a Context-Dependent Resistance to TGF- 

(2010) C. O. Adams et al.   JOURNAL OF IMMUNOLOGY

Mammary tumors with diverse immunological phenotypes show differing sensitivity to adoptively transferred CD8+ T cells lacking the Cbl-b gene

(2009) Taimei Yang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer

(2009) P.-Y. Pan et al.   CANCER RESEARCH

Cyclophosphamide Augments Antitumor Immunity: Studies in an Autochthonous Prostate Cancer Model

(2009) S. Wada et al.   CANCER RESEARCH

Immunity to Murine Prostatic Tumors: Continuous Provision of T-Cell Help Prevents CD8 T-Cell Tolerance and Activates Tumor-Infiltrating Dendritic Cells

(2009) K. A. Shafer-Weaver et al.   CANCER RESEARCH

Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824

(2009) D. D. Vo et al.   CANCER RESEARCH

Immune Therapy for Cancer

(2008) Michael Dougan et al.   Annual Review of Immunology

TGF-β and tumors—an ill-fated alliance

(2008) Niki M Moutsopoulos et al.   CURRENT OPINION IN IMMUNOLOGY